SCHEMBL89374

SCHEMBL89374

CC(=O)OC1C=Cc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.49
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 1/20 0.38
RET P07949 2/20 0.36
HPGD P15428 1/20 0.34
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.33
BRD4 O60885 1/20 0.33
CCL2 P13500 1/20 0.33
MEN1 O00255 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
HTR6 P50406 1/20 0.33
HTR2A P28223 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ATM Q13315 1/20 0.32
CYP2D6 P10635 1/20 0.32
P2RX4 Q99571 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8697270 1.00 POLB (0.49) POLBALDH1A1KDM4ERETHPGD
SCHEMBL8694188 1.00 POLB (0.49) POLBALDH1A1KDM4ERETHPGD
SCHEMBL28304038 0.98 POLB (0.47) POLBALDH1A1KDM4ERETHPGD
SCHEMBL6700611 0.85 POLB (0.39) POLBALDH1A1KDM4ERETKMT2A
SCHEMBL30931450 0.84 POLB (0.38) POLBALDH1A1KDM4ERETKMT2A
SCHEMBL17222502 0.83 POLB (0.37) POLBALDH1A1KDM4ERETHPGD
SCHEMBL459671 0.83 POLB (0.37) POLBALDH1A1KDM4ERETHPGD
SCHEMBL15664847 0.83 POLB (0.37) POLBALDH1A1KDM4ERETKMT2A
SCHEMBL28022821 0.82 POLB (0.39) POLBALDH1A1KDM4EHPGDKMT2A
SCHEMBL27926152 0.82 ALDH1A1 (0.38) POLBALDH1A1KDM4ERETHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4116 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216311-A1 FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2024-07-04 US claimed
WO-2024044849-A1 DILUTABLE COMPOSITIONS AND PROCESSES FOR EXTRACTING AND REFINING POORLY WATER-SOLUBLE POLAR OILS FROM BIOMASS MICELLAE DELIVERY SYSTEMS INC. (CA) 2024-03-07 WO claimed
US-20230405003-A1 APPLICATION OF THYMIDINE DERIVATIVE IN PREPARATION OF DRUGS ONQUALITY PHARMACEUTICALS CHINA LTD. (CN) 2023-12-21 US claimed
EP-4271414-A1 FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES The Governing Council of the University of Toronto (CA) 2023-11-08 EP claimed
EP-4238571-A1 APPLICATION OF THYMIDINE DERIVATIVE IN PREPARATION OF DRUGS OnQuality Pharmaceuticals China Ltd. (CN) 2023-09-06 EP claimed
WO-2022140843-A1 FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2022-07-07 WO claimed
EP-3512503-A1 LIPOSOMAL FORMULATIONS Nanyang Technological University (SG) 2019-07-24 EP claimed
US-20190216735-A1 LIPOSOMAL FORMULATIONS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2019-07-18 US claimed
US-10076641-B2 Methods and systems for delivering substances into luminal walls THE SPECTRANETICS CORPORATION (US) 2018-09-18 US claimed
WO-2018052373-A1 LIPOSOMAL FORMULATIONS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2018-03-22 WO claimed
US-20050215565-A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents BIOGEN MA INC. 2005-09-29 US claimed
US-20050069541-A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) 2005-03-31 US claimed
EP-1499599-A1 SUBSTITUTED PYRAZINE DERIVATIVES Pharmacia & Upjohn Company LLC (US) 2005-01-26 EP claimed
WO-2004066932-A2 COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS ELAN PHARMACEUTICALS INC. (US) 2004-08-12 WO claimed
WO-2004066931-A2 COMPOSITION FOR AND TREATMENT OF DEMYELINATING DISEASES AND PARALYSIS BY ADMINISTRATION OF REMYELINATING AGENTS ELAN PHARMACEUTICALS INC. (US) 2004-08-12 WO claimed
US-20030212123-A1 COX-2 selective carprofen for treating pain and inflammation in dogs PFIZER INC. 2003-11-13 US claimed
WO-2003091225-A1 SUBSTITUTED PYRAZINE DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 2003-11-06 WO claimed
US-20030176421-A1 PROKINETIC AGENTS FOR TREATING GASTRIC HYPOMOTILITY AND RELATED DISORDERS WATSON JOHN W (US) 2003-09-18 US claimed
EP-0642336-A1 USE OF NSIAD IN THE TREATMENT OF DEMENTIA UNIVERSITY OF BRITISH COLUMBIA (CA) 1995-03-15 EP claimed
WO-1993024115-A1 ANTI-RHEUMATOID ARTHRITIC DRUGS IN THE TREATMENT OF DEMENTIA THE UNIVERSITY OF BRITISH COLUMBIA (CA) 1993-12-09 WO claimed